Studies
Research and Studies involving CBD
Chronic pain and Inflammation- Authors of a study published in the 2012 Journal of Experimental Medicine found that CBD significantly reduced inflammation and chronic pain in mice and rats. Researches reported that, "systemic and intrathecal administration of cannabidiol (CBD), a major nonpsychoactive component of marijuana, and its derivatives significantly suppress chronic inflammatory and neuropathic pain without causing apparent analgesic tolerance in rodents."
​
Anxiety-A 2011 study by a group of scientist prescribed 600 mg of CBD to people with Generalized Social Disorder (SAD) and found that participants had reduced levels of anxiety, cognitive impairment, and speech discomfort. It is believed that CBD can increase serotonin levels in the body, which ten to be low in people who suffer from anxiety. Researchers believe CBD could help anxiety disorders, panic disorder, social anxiety disorder, obsessive compulsive disorder, and post -traumatic stress disorder.
​
Nicotine Withdrawals- Researchers from the Clinical Psychopharmacology Unit of the University of London published a study in 2013 showing smokers who used CBD experienced reduce nicotine cravings and smoked about 40% fewer cigarettes than the controlled group. The placebo group showed no significant difference in their consumption of nicotine. The result was so remarkable because the subjects weren’t asked to stop smoking. Another study found CBD to be a promising treatment for heroin addicts.
​
Opioid Withdrawals- For this study, the researchers investigated the effects of CBD on heroin addicts. For 3 days they gave heroin-dependent individuals a dose of CBD or a placebo. Next, they then showed them video cues that were either heroine related of neutral. Consecutively, they measured drug cravings there were induced by the cues. In all subjects, CBD decreased their heroine cravings.
​
Epilepsy- CBD is increasingly being used to treat epilepsy. A team of medical researchers and doctors published their findings in the June 2014 Epilepsia which highlighted the anti-seizure properties of the compound, as well as its low risk side effects. It appears that CBD has a positive effect of various neurological disorders linked to epilepsy, including neurodegeneration and psychiatric illnesses.
​
​
​
Cancer-A review in the British Journal of Clinical Pharmacology from 2013 cited the cancer-blocking effects of cannabidiol suppressing the growth and spread of cancer cells.
​
Acne-A team of researchers from Europe and Japan published their study in the Journal of Clinical Investigation showing that CBD lowers the production of sebum in the body, thereby also reducing acne.
Schizophrenia- CBD has been shown to have antipsychotic effects and may be useful for those suffering from schizophrenia. Researchers remarked, "Cannabidiol displayed a markedly superior side-effect profile. Moreover, cannabidiol treatment was accompanied by a significant increase in serum anandamide levels, which was significantly associated with clinical improvement.
​
Type-1 Diabetes- Research on non-obese diabetic mice found that cannabidoil treatment significantly reduced pancreatic inflammation and lowered the incidence of diabetes.
​
Alzheimer's Disease- A study published in the Journal of Alzheimer's Disease study stated, "Our findings provide the first evidence that CBD may have potential as a preventative treatment for AD with a particular relevance for symptoms of social withdrawal and facial recognition.
​
Stimulates Appetite- CBD binds itself to the body's cannabinoid receptors and has been found to stimulate appetite according to the National Cancer Institute.
​
Other conditions in which CBD could help aid:
​
-Lupus
-Restless Leg Syndrome
-Eczema
-Fibromyalgia
-Rheumatoid Arthritis
-Psoriasis
-Osteoporosis
-Parkinson's Disease
-Pediatric conditions
​
​
​
​
​
​
Book References:
​